Edinburgh PhD: How ROGDI may help sustain synaptic communication

Edinburgh PhD: How ROGDI may help sustain synaptic communication

This Edinburgh doctorate asks whether ROGDI helps nerve endings sustain communication by controlling the assembly of V-ATPase, the pump that supports synaptic-vesicle refilling. It combines human-neuron models, quantitative imaging and physiological measurements under supervisors with complementary cell-biology and human disease-modelling expertise. Its distinctive opportunity is to connect a defined cellular mechanism with a disease-associated protein within a four-year programme that includes a professional placement. The project remains mechanistic research: it does not offer an established therapy or a clinical qualification.

EastBio advertises a competitive funding route for international applicants; the overseas-fee top-up waiver is stated for successful EastBio international awardees and is not established for the alternative Doctoral College Award. Individual award terms and the 2027 stipend rate remain unknown. The immediate decisions concern the one-project application limit, prescribed documents and the 16 November 2026 deadline. The cited project announcement specifies a midday deadline without a stated time zone and allows references to follow; the cited central instructions require references by the deadline. Resolve that conflict and confirm the exact topic remains available before committing the one permitted application.

1. Research problem, doctoral work and field outlook

Sustained neurotransmission depends on recovering and refilling a limited local pool of vesicles as well as releasing their contents. V-ATPase supplies the proton gradient needed for refilling: its cytoplasmic V₁ motor must dock with the membrane V₀ channel for the pump to work. How nerve endings regulate that assembly remains unresolved. This project tests whether ROGDI, part of the mammalian mRAVE complex, acts directly at synapses to control the process. ROGDI mutations cause Kohlschütter–Tönz syndrome (KTS), which includes epilepsy and cognitive impairment, but the genetic link alone does not establish the proposed presynaptic mechanism or explain every disease feature.

A recent field paper strengthens the rationale without settling this doctorate's question. Nardone and colleagues' 2025 Nature Structural & Molecular Biology original, A heterotrimeric protein complex assembles the metazoan V-ATPase upon dissipation of proton gradients, identifies mRAVE-related assembly and acidification functions. Neither advertised supervisor is an author. Its complete publisher abstract and selected introductory passages were read; it is supporting field evidence, separate from the three supervisor papers below. General molecular assembly evidence cannot simply be transferred into proof of ROGDI's precise role in human synapses. Field original.

The doctoral work connects three complementary questions:

• Models: use CRISPR-based genome engineering to establish tagged, degradable, knockout and patient-mutant hiPSC-ROGDI lines and differentiate them into relevant neuron types.
• Location and timing: use live-cell, single-molecule and super-resolution imaging to examine where and when ROGDI interacts with V-ATPase at synapses.
• Function: use pH imaging, patch-clamp and MEA recordings to compare re-acidification and synaptic function under chronic versus acute ROGDI depletion.

Together, these comparisons should connect protein location and timing with a functional explanation of sustained communication. A better-supported causal link between vesicle function and a disease-associated protein would be a meaningful doctoral contribution. It remains an intended outcome, not an established result, promised publication or treatment claim.

The breadth of the work makes training and specialist support central to feasibility. Distinguishing a local synaptic effect from broader cellular dysfunction requires careful interpretation across measurement types and model contexts. The announcement lists genome engineering, human stem-cell/neuron work, imaging, electrophysiology, three-dimensional cellular contexts and Python analysis as training areas. It does not make prior mastery of every technique an entry condition. The practical question is which elements form the student's core contribution and which receive specialist support. Public descriptions do not establish access to particular models, individual datasets, ethical permissions or unrestricted instrument time. The official school funding page supplies common application and funding context; the project-specific tasks are described in the cited complete project announcement.

2. School, subject environment and doctoral training

The awarding institution is the University of Edinburgh. The advertised Euclid route is PhD in Biological Sciences with Internship, located academically in the School of Biological Sciences, College of Science and Engineering. Collaboration with Selvaraj's Edinburgh neuroscience environment does not imply another awarding university or a joint degree. The current 2027 programme describes four years full-time. EastBio states that applicants needing a study visa must use full-time study; its programme is not a remote doctorate. The programme's part-time header says eight years while its overview says 84 months, an inconsistency to resolve only if that route is relevant. Formal programme.

University rankings, subject rankings and project resources answer different questions. The ranking provider places Edinburgh 35 overall in QS World University Rankings 2027. The programme separately cites 2024 QS and THE biological-sciences positions within the top five in the UK and top 30 worldwide. Those are dated subject claims, not fresh 2027 neuroscience rankings. For this project, the more direct evidence is the combination of quantitative cell biology, imaging and human-neuron research across the two groups. The official programme lists specialist imaging and wider molecular/cellular facilities, while the UKDRI Selvaraj laboratory describes a human neural disease-modelling context. These indicate available institutional expertise rather than a guarantee of personal allocation. QS institutional record.

The degree has substantive progression requirements. The first year is probationary, with ten-week and ten-month reports; the latter includes research/literature assessment and an oral component. Annual progression must be passed, with later poster and oral presentations. The programme describes a thesis of up to 100,000 words and a viva, plus internship reporting, including a short separately assessed report. These requirements make research communication and maintaining progress through several method areas important parts of the doctorate, beyond laboratory technique alone.

EastBio provides core training in years one and two, while later years concentrate on research with further optional development. The three-month professional internship is mandatory in the advertised funding/training route. The programme's generic provision for a longer internship with approval is not an entitlement to extend the EastBio placement or funding. Its professional purpose includes experiencing work beyond academic research, developing transferable skills and contacts. An individual host, location and future job are not guaranteed. The published 2026–27 training calendar is informative about programme structure, not a fixed personal 2027 timetable. Training overview, Placements.

3. Supervisors, recent originals and evidence limits

Current institutional profiles identify Dhanya K. Cheerambathur as Senior Research Fellow in Biological Sciences, accepting PhD students, and Bhuvaneish T. Selvaraj as Senior Research Fellow, linked to the Centre for Clinical Brain Sciences and UK Dementia Research Institute. Historical fellowship appointments should not be promoted into a current professorial title. Cheerambathur's research concerns cellular machinery, cytoskeletal organisation and neuronal structure/maintenance; Selvaraj's concerns human neural models, axonal homeostasis and neurodegenerative disease context. Their complementarity is credible, but public profiles do not specify weekly supervision division or which facilities a new student personally controls. Cheerambathur profile, Selvaraj profile.

The three recent peer-reviewed originals below illustrate complementary expertise. The discussion of each paper's contribution and author roles is limited to its complete primary author abstract and ordered author list; it does not assess the full paper.

Neuronal cytoskeletal function: JCB, 2025 issue

The Kinetochore Protein KNL-1 Regulates the Actin Cytoskeleton to Control Dendrite Branching, Journal of Cell Biology 224(2), e202311147, DOI 10.1083/jcb.202311147, appeared online on 3 December 2024.

Ordered authors are Henrique Alves Domingos, Mattie Green, Vasilis R. Ouzounidis, Cameron Finlayson, Bram Prevo and Dhanya K. Cheerambathur.

Cheerambathur is last of six and a corresponding author. The abstract links a cellular machinery protein with sensory-neuron dendrite organisation and maintenance in C. elegans. It supports neuronal cell-biology expertise; it is not direct evidence for human ROGDI-mediated vesicle acidification. Final institutional record and abstract.

Mechanistic cell biology: Nature Communications, 2024

Kinetochore dynein is sufficient to biorient chromosomes and remodel the outer kinetochore, 15, 9085, DOI 10.1038/s41467-024-52964-5, was published on 21 October 2024.

Authors are Bram Prevo, Dhanya K. Cheerambathur, William C. Earnshaw and Arshad Desai.

Cheerambathur is second of four; Prevo and Desai are the corresponding authors. The work separates aspects of chromosome organisation and kinetochore remodelling in a C. elegans embryonic context. Its relevance is rigorous quantitative mechanism research, not an established synaptic disease result or evidence of Cheerambathur's sole leadership. Final institutional record and abstract.

Human neuronal model context: Nature Neuroscience, 2026

Astrocytes regulate axonal mitochondrial transport deficits in C9ORF72 amyotrophic lateral sclerosis motor neurons, DOI 10.1038/s41593-026-02464-0, was published online on 7 October 2026.

Ordered authors are Maria Stavrou, Áine Bríd Heffernan, Roderick N. Carter, Owen Dando, Zoeb Jiwaji, Karen Burr, Jyoti Nanda, David Villarroel-Campos, Alya Masoud Abdelhafid, Justyna Cholewa-Waclaw, Daniel Soong, David Story, Giampietro Schiavo, Giles E. Hardingham, Siddharthan Chandran and Bhuvaneish T. Selvaraj.

Selvaraj is last of 16 and shares correspondence with Chandran. The abstract shows that astrocyte context affects transport phenotypes in human stem-cell-based motor-neuron models. This supports expertise in interpreting human neural models while warning against attributing every phenotype to neurons alone. It concerns ALS/C9ORF72, not proof of the advertised KTS mechanism or a clinical therapy. Final author-institution abstract.

All three assessments are limited to complete final author abstracts and authorship/metadata. No whole-paper, complete Methods–Results–Conclusions or supplementary-information assessment is available, so detailed methodological robustness and reproducibility remain beyond the reading scope. The 2026 abstract is the final UKDRI version, corroborated by publisher-indexed publication and correspondence metadata.

4. Funding, dates and living costs

The announcement offers four-year competitive support through either an EastBio BBSRC Doctoral Landscape Award or an Edinburgh Doctoral College Award; they are alternatives. It describes support including a UKRI-rate stipend, project costs and tuition. The cited EastBio FAQ permits international applicants and sets a 30% annual cap on international intake across the EastBio network. This is a network-wide proportion, not a quota for this project or an individual applicant's admission probability. The overseas-fee top-up waiver is stated for successful international EastBio awardees; the cited materials do not establish that it extends to the Doctoral College Award. The individual's allocated award, terms and 2027 stipend rate remain unconfirmed. International eligibility and coverage.

School funding information confirms an alternative Doctoral College award with tuition and a four-year stipend, incorporated into EastBio recruitment. Its school project grant is £5,000 in each of years one to three and £1,000 in year four. These are research funds, not extra personal income. The announcement says no separate application is needed for that alternative; the two awards should not be presented as simultaneous payments. Obtain the actual allocated award's conditions before acceptance. School funding table.

The scheduled start is 1 October 2027. Recruitment closes on 16 November 2026; the project announcement specifies midday without a time zone. The cited central instructions require references by the deadline and reject late applications, whereas the cited project announcement permits a two-week reference grace period. Do not rely on the grace period without written clarification. The selection calendar gives invitations on 22 February 2027, interviews in the week of 8 March and decisions in the week of 22 March; these are the cohort timetable, not promises of a personal invitation or exact interview slot. The EDI survey's longer availability window does not extend application closing. How to apply, Selection process.

For scale, UKRI's published 2026/27 minimum stipend is £21,805, with a £5,238 Home-fee rate. These are dated reference rates, not a 2027/28 award quotation. Generic UKRI Home-fee contributions should not be used to negate EastBio's specific international top-up waiver. Edinburgh estimates £18,504 a year or £1,542 a month for a single postgraduate in 2026/27, calculated in March 2026 and excluding tuition/study costs. Prices may rise; a scholarship-minus-budget calculation would not establish personal net savings. UKRI rates, Official living budget.

EastBio explicitly excludes visa and immigration-health-surcharge expenses. The cited UK government guidance lists £558 for an outside-UK Student visa application and £776 per visa year for student IHS; these are dated planning references, not guaranteed 2027 charges. IHS is an upfront total based on actual visa duration and rounding rules, not necessarily exactly four annual charges. Travel, moving and initial housing cash also need an individual budget; no reimbursement of these is established here. These specified upfront costs warrant planning, while competition or an unpublished future rate alone does not establish a material tuition-and-maintenance funding gap. Student visa, IHS.

5. Entry, English and application preparation from China

The programme asks for a relevant UK 2:1 honours degree or equivalent, research understanding and appropriate experience. EastBio explicitly says a master's degree is not universally required; a lower undergraduate result may be considered with relevant postgraduate or substantial professional experience. This is a case-assessment route, not a guarantee of exemption. China's qualification page requires recognised institutions, but its published 80/80–85% equivalency table explicitly covers postgraduate taught programmes and two named MScR degrees. It must not be converted into this PhD's universal Chinese percentage threshold. The PhD note makes a master's conditional on the particular programme's Qualifications section. China qualification scope.

The cited 2027/28 programme English requirements supersede older indexed thresholds. IELTS Academic requires 6.5 overall and 6.0 in each component, without One Skill Retake. TOEFL iBT, including Home Edition, requires 92 overall and 23 per component for tests before 21 January 2026; from that date it requires 4.5 overall and 4.5 in each component, with no MyBest combination. Other accepted tests have their own published scores. IELTS, TOEFL and the listed Oxford tests must be no more than two years old on the first day of the programme-start month; other language tests have a three-and-a-half-year limit. An English-medium degree qualifies only under the university's country/institution and recency conditions, not merely because a Chinese applicant studied some courses in English. EastBio allows initial application before an English test, but evidence may be required before a formal offer.

There is one EastBio project application across all host institutions. Complete the anonymous EDI survey and put its response ID on the prescribed EastBio form. Submit the form and transcripts, with official English translations where needed, and two references using the EastBio template. Academic or professional referees are permitted; the proposed project supervisor cannot be a referee. The FAQ says additional documents such as a CV are disregarded. Euclid's automatic reference invitation does not replace the template requirement. The announcement instructs applicants to upload the EastBio form in the Research Proposal section of Biological Sciences with Internship and identify the topic, supervisors and expected funding. That instruction does not itself create a requirement to devise another independent proposal. The linked complete DOCX form was not inspected, so its remaining fields should be checked directly before submission.

Useful preparation is evidence of one well-understood research contribution: the question, interpretation, uncertainty and personal role, explained clearly enough for the short prior-research presentation. Quantitative analysis and critical comparison of model systems are relevant strengths; the advertised specialist techniques remain training opportunities rather than a fabricated mandatory pre-entry checklist. A wholly remote doctorate or an immediate clinical-practice qualification would not match the published route.

For immigration, confirm CAS and financial/English evidence through the actual offer process. Chinese nationality alone neither exempts an applicant from ATAS nor establishes that this particular research requires it. The university must determine the applicable subject code and research scope. Do not infer a sensitive-subject classification merely from the project title. ATAS rules.

6. Career implications

The likely transferable strengths are quantitative cellular analysis, imaging/data interpretation, research-model evaluation and interdisciplinary communication. These can inform academic neuroscience and research roles in biotechnology or pharmaceutical development, but a research doctorate does not automatically confer clinical registration. The British Neuroscience Association's professional-development resources and EastBio's nonacademic internship provide concrete routes for exploring careers. They do not establish a current vacancy count, salary premium or guaranteed placement. Professional development context.

7. Questions by decision stage

Before applying: confirm the exact project's current availability, the midday time zone and whether the central reference deadline supersedes the advertised grace period. Establish Chinese degree equivalence and any outstanding English evidence. Choose the one permitted project, complete the EDI/form/template requirements and prepare references for the conservative earlier date.

At interview: ask what target-specific preliminary findings already exist, which proposed results are still hypotheses, and how the student will divide work between the two groups. Clarify core versus supporting methods, supervision responsibilities, training support, physical work locations, ethics and resource permissions. Ask how the compulsory internship fits annual milestones and the research plan.

Before accepting: obtain written confirmation of the allocated award, full international tuition coverage, maintenance duration/rate and progression conditions, plus research/placement expense rules. Plan for the expressly excluded visa/IHS charges; confirm relocation reimbursement and budget accordingly. Confirm practical supervision, facilities and the applicable degree requirements. Published materials describe competitive funding routes but do not confirm an individual's allocated award or terms; those unknowns do not by themselves demonstrate a funding deficit.

Evidence and Sources

Project and recruitment details are limited to the cited project announcement and recruitment instructions. The recruitment module in those materials does not show the project-specific body, so current acceptance remains unknown. The three supervisor originals are discussed only from each complete final author abstract and ordered author list; this account does not assess the full papers, complete Methods–Results–Conclusions or supplementary information. The 2026 abstract is the final UKDRI version, corroborated by publisher-indexed publication and correspondence metadata. The separate non-supervisor 2025 field paper is discussed from its complete publisher abstract and selected introductory passages. Programme, China/English requirements and staff-profile claims are limited to cited official programme, admissions and staff sources; these reading limits do not support detailed judgments of the papers’ methodological robustness or reproducibility.

• S03 · Dhanya K Cheerambathur current institutional profile
• S04 · Bhuvaneish T Selvaraj current official profile and Research body
• S05 · Selvaraj Lab at UK Dementia Research Institute
• S06 · The Kinetochore Protein KNL-1 Regulates the Actin Cytoskeleton to Control Dendrite Branching
• S07 · Kinetochore dynein is sufficient to biorient chromosomes and remodel the outer kinetochore
• S08 · Astrocytes regulate axonal mitochondrial transport deficits in C9ORF72 amyotrophic lateral sclerosis motor neurons
• S09 · A heterotrimeric protein complex assembles the metazoan V-ATPase upon dissipation of proton gradients
• S10 · EastBio current frequently asked questions
• S11 · EastBio how to apply for 2027
• S12 · EastBio selection process and 2027 recruitment timeline
• S13 · School of Biological Sciences current PhD funding table
• S14 · Biological Sciences with Internship PhD 2027/28 formal programme
• S15 · EastBio current training overview
• S16 · EastBio professional internships and placements
• S17 · Edinburgh official postgraduate living costs 2026/27
• S18 · China qualification equivalencies: limits of the published table
• S19 · QS Edinburgh institution ranking history
• S20 · UKRI current training-grant stipend and Home-fee rates
• S21 · UK Student visa official fee and route
• S22 · Immigration health surcharge current student charge
• S23 · ATAS official subject and nationality conditions
• S24 · British Neuroscience Association professional development and careers context